India plans insurance reforms to rein in healthcare costs, sources say
Authorities are considering a set of health insurance reforms aimed at standardising treatment rates, coverage, and billing practices across insurers and hospitals
A regulatory panel comprising regulators, insurance industry representatives, hospitals, and industry body representation is expected to submit its recommendations by the end of 2026
Proposed reforms include benchmarked treatment rates agreed between insurers and hospitals, a mandatory common/standardised health insurance product, and a uniform list of admissible treatments
The reforms also aim to expand the nationwide digital claims exchange to speed up settlements and curb fraudulent claims
The stated objectives are to reduce medical inflation, cut down fraudulent or unwarranted claims, and expand overall insurance coverage in the country
Insurance Regulatory and Development Authority of India (IRDAI)
IRDAI is the statutory regulator for the insurance sector in India, established under the Insurance Regulatory and Development Authority Act, 1999, following the recommendations of the Malhotra Committee (1994) on insurance sector reforms.
Key Details
- Composition under Section 4 of the IRDAI Act, 1999: a chairperson and up to nine members (not more than five whole-time members), all appointed by the Central Government, with at least one member possessing expertise in life insurance, general insurance, or actuarial science
- Section 14 functions include issuing, renewing, and cancelling registration certificates of insurers, protecting policyholder interests, specifying codes of conduct for intermediaries, and regulating insurance products and rates
- IRDAI already regulates premium hikes — for instance, it has capped annual premium increases for senior citizen health policies
IRDAI is reported to be leading the current reform panel — alongside industry bodies such as CII, hospitals, and insurers — that is expected to recommend benchmarked treatment rates and standardised products by the end of 2026.
National Health Claim Exchange (NHCX)
The NHCX is a digital, single-window platform that connects hospitals, insurers, and policyholders to standardise and speed up health insurance claim processing. It was developed by the National Health Authority (NHA) as part of the Ayushman Bharat Digital Mission (ABDM), in collaboration with IRDAI.
Key Details
- IRDAI issued a circular in June 2023 directing all insurers to join the NHCX
- The platform uses FHIR-compliant e-claim data formats through standard APIs for interoperability between hospitals and insurers
- As adoption progressed through 2023-24, major insurers (e.g., HDFC Ergo was among the first) and hospitals came onto the exchange, reducing manual, paper-based claims processing
- The exchange is distinct from the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) claims processing, though both fall under the wider Ayushman Bharat Digital Mission umbrella
The "nationwide claims exchange" being expanded under the current reform plan is the NHCX; broadening its adoption and standardising the underlying billing data are central to the government's plan to cut fraudulent claims and settlement delays.
Medical Inflation and Health Insurance Penetration in India
Medical inflation refers to the year-on-year rise in the cost of healthcare services and treatment, which in India runs well above general Consumer Price Index (CPI) inflation, driven by rising hospital costs, technology adoption, and information asymmetry between insurers, hospitals, and patients.
Key Details
- Industry estimates place India's medical inflation at roughly 12-14% annually, among the highest in Asia — compared to general CPI inflation typically in the 4-6% range
- Industry estimates suggest 10-15% of health insurance claims involve unwarranted or fraudulent billing, a key driver of rising premiums
- Health insurance penetration in India remains low relative to global peers, with out-of-pocket health expenditure historically forming a large share of total health spending — a structural gap that schemes like Ayushman Bharat PM-JAY (launched 2018) and now these regulatory reforms aim to close
- Standardisation of treatment rates (a "rate card" approach) mirrors similar mechanisms already used under PM-JAY, where package rates for procedures are pre-fixed
The proposed benchmarked treatment rates and standardised insurance products are a direct regulatory response to this persistently high medical inflation rate and the associated fraud/billing-dispute problem, aiming to bring private health insurance pricing discipline closer to the package-rate model already used in public schemes like PM-JAY.
- Reported medical inflation in India: approximately 12-14% per year (industry estimates)
- Estimated fraudulent/unwarranted claims: 10-15% of total health claims
- IRDAI established under the IRDAI Act, 1999, following the Malhotra Committee (1994) recommendations
- IRDAI composition: chairperson + up to 9 members (max 5 whole-time), Central Government appointed
- NHCX: developed by the National Health Authority under Ayushman Bharat Digital Mission; IRDAI circular mandating insurer participation issued June 2023
- Reform panel recommendations expected by end of 2026, with implementation to follow
- Private/standalone health insurers raised premiums by roughly 10-15% for the 2025-26 policy cycle